Regulation of calcium signaling in the human malaria parasite
Regulation of calcium signaling in the human malaria parasite
批准号:
9759759
负责人:
Silvia N Moreno
金额:
$18.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-10 至 2021-07-31
关键词:
AffectAnimal ModelAntimalarialsAreaBackBindingBinding ProteinsBiochemicalBiologicalBiological AssayBiological ProcessBiologyBiotinBuffersCRISPR/Cas technologyCalciumCalcium SignalingCalcium ionCalnexinCellsCessation of lifeClinicClinicalCytoplasmCytosolDataDefectDiseaseDrug TargetingDrug resistanceDrug usageEndoplasmic ReticulumErythrocytesGenesGeneticGenomeGoalsGrowthHomeostasisHumanInfectionInositolIonsKnock-outLabelLife Cycle StagesLigaseMalariaMalaria VaccinesMolecularOrganellesOrganismParasitesPathway interactionsPlasmodiumPlasmodium falciparumPopulationProteinsRegulationResearchResistanceResistance developmentRoleRyanodine Receptor Calcium Release ChannelSexual DevelopmentSignal PathwaySignal TransductionSystemTransmembrane Domainasexualbaseconditional mutantdrug developmentexperimental studyfallsgene therapyhuman diseaseknock-downloss of functionmortalitymutantnew therapeutic targetnovelobligate intracellular parasiteparasite invasionreceptorresistant strainresponseuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The deadliest form of human malaria is caused by the eukaryotic parasite Plasmodium falciparum,
which is responsible for nearly 450,000 deaths every year. Nearly half of the world’s population lives in
areas where malaria is endemic, resulting in almost ~250 million infections each year. As yet, there are
no effective vaccines against malaria and antimalarial drugs are the mainstay of treatment.
Unfortunately, the parasite has gained resistance to all antimalarial drugs used in the clinic and these
drug-resistant strains are spreading throughout the world. Thus, it is crucial that we constantly identify
potential novel drug targets to stay ahead of this deadly disease. Understanding the signaling pathways
that drive the biology of the parasite will provide new antimalarial drug targets that are unique to the
parasite and absent in the host. Calcium ion (Ca2+) signaling has emerged as one of the major drivers
of the life cycle of P. falciparum. The goal of this proposal is to study Ca2+ signaling and the pathways
that regulate ion fluctuations in malaria parasites. In P. falciparum, similar to other eukaryotic
organisms, the cytoplasmic levels of Ca2+ is very low and its concentration rises in the cytoplasm in
response to specific signals. This increased cytosolic Ca2+ results in a signaling cascade that that is
essential for the life cycle of the parasite. Once the signal subsides, the levels of cytosolic Ca2+ falls
back via uptake into intracellular Ca2+ stores, such as the endoplasmic reticulum. The P. falciparum
genome lacks several canonical genes that are known to be essential for Ca2+ signaling in other well-
studied eukaryotic organisms. Therefore, we will target the only soluble protein with Ca2+ binding
domains that localizes to the major intracellular Ca2+ store, the endoplasmic reticulum. We hypothesize
that this protein regulates the release and uptake of Ca2+ from this organelle. Our preliminary data show
that this gene is essential for the asexual life cycle of the parasite and is required for the invasion of the
parasite into its host red blood cell. We will utilize genetic, cellular, and biochemical approaches to
define the role of this gene in regulating Ca2+ signaling and the invasion of P. falciparum into the host
cell. These include the use of genetically encoded Ca2+ indicators to reveal the fluctuations of Ca2+
during the intraerythrocytic life cycle of P. falciparum as well as the effect of genetic interventions on the
homeostasis of Ca2+. A second independent proximity-based labeling approach will be undertaken to
isolate and discover novel partners of the targeted gene to define the network of genes required to
regulate the flow of Ca2+ within the P. falciparum infected human red blood cells. Achieving the aims of
this study will reveal the essential parasite-specific pathways that regulate Ca2+ signaling, which can be
targeted for antimalarial drug development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of polyphosphate in Toxoplasma gondii
-
批准号:10681078
-
项目类别:
-
资助金额:$21.28万
-
财政年份:2023
-
负责人:Silvia N Moreno
-
依托单位:
Divergent Calcium Channels of the Apicomplexan parasite Toxoplasma gondii
-
批准号:10681807
-
项目类别:
-
资助金额:$62.48万
-
财政年份:2023
-
负责人:Silvia N Moreno
-
依托单位:
Validation of the ubiquinone synthesis pathway of Toxoplasma gondii as a novel drug target
-
批准号:10707505
-
项目类别:
-
资助金额:$43.11万
-
财政年份:2022
-
负责人:Silvia N Moreno
-
依托单位:
Validation of the ubiquinone synthesis pathway of Toxoplasma gondii as a novel drug target
-
批准号:10608408
-
项目类别:
-
资助金额:$41.57万
-
财政年份:2022
-
负责人:Silvia N Moreno
-
依托单位:
Elements of the Ca2+ signal transduction pathway of Toxoplasma gondii
-
批准号:10154355
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2020
-
负责人:Silvia N Moreno
-
依托单位:
Anti-Toxoplasma isoprenoid pathway inhibitors and the host immune response
-
批准号:10117182
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2020
-
负责人:Silvia N Moreno
-
依托单位:
Elements of the Ca2+ signal transduction pathway of Toxoplasma gondii
-
批准号:10318661
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2020
-
负责人:Silvia N Moreno
-
依托单位:
The Toxoplasma apicoplast and calcium signaling
-
批准号:9384713
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Silvia N Moreno
-
依托单位:
The Toxoplasma apicoplast and calcium signaling
-
批准号:10051384
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Silvia N Moreno
-
依托单位:
The Toxoplasma apicoplast and calcium signaling
-
批准号:9229418
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Silvia N Moreno
-
依托单位:
Genetically Encoded Calcium Indicators in Toxoplasma gondii
-
批准号:8874890
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2014
-
负责人:Silvia N Moreno
-
依托单位:
Genetically Encoded Calcium Indicators in Toxoplasma gondii
-
批准号:8786763
-
项目类别:
-
资助金额:$22.35万
-
财政年份:2014
-
负责人:Silvia N Moreno
-
依托单位:
Targeting Host and Apicomplexan Isoprenoid Pathways
-
批准号:8496713
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2012
-
负责人:Silvia N Moreno
-
依托单位:
Targeting Host and Apicomplexan Isoprenoid Pathways
-
批准号:9089810
-
项目类别:
-
资助金额:$43.48万
-
财政年份:2012
-
负责人:Silvia N Moreno
-
依托单位:
Targeting Host and Apicomplexan Isoprenoid Pathways
-
批准号:8853603
-
项目类别:
-
资助金额:$43.48万
-
财政年份:2012
-
负责人:Silvia N Moreno
-
依托单位:
Targeting Host and Apicomplexan Isoprenoid Pathways
-
批准号:8391318
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2012
-
负责人:Silvia N Moreno
-
依托单位:
Targeting Host and Apicomplexan Isoprenoid Pathways
-
批准号:8890100
-
项目类别:
-
资助金额:$43.48万
-
财政年份:2012
-
负责人:Silvia N Moreno
-
依托单位:
The plant-like vacuole of Toxoplasma gondii
-
批准号:8385516
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2011
-
负责人:Silvia N Moreno
-
依托单位:
The plant-like vacuole of Toxoplasma gondii
-
批准号:8258564
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2011
-
负责人:Silvia N Moreno
-
依托单位:
The plant-like vacuole of Toxoplasma gondii
-
批准号:8585022
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2011
-
负责人:Silvia N Moreno
-
依托单位:
海外基金